Ispronicline
Ispronicline structure
|
Common Name | Ispronicline | ||
|---|---|---|---|---|
| CAS Number | 252870-53-4 | Molecular Weight | 234.34 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C14H22N2O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of IsproniclineIspronicline (TC-1734), an orally active, brain-selective α4β2 nicotine acetylcholine receptor (nAChR) partial agonist, has shown memory-enhancing properties in rodents and a good tolerability profile. Ispronicline binds to the α4β2 nAChR with high affinity (Ki=11 nM) and is highly selective to other nAChRs such as α7 nAChR and α3β4 nAChR[1][2]. |
| Name | (E,2S)-N-methyl-5-(5-propan-2-yloxypyridin-3-yl)pent-4-en-2-amine |
|---|---|
| Synonym | More Synonyms |
| Description | Ispronicline (TC-1734), an orally active, brain-selective α4β2 nicotine acetylcholine receptor (nAChR) partial agonist, has shown memory-enhancing properties in rodents and a good tolerability profile. Ispronicline binds to the α4β2 nAChR with high affinity (Ki=11 nM) and is highly selective to other nAChRs such as α7 nAChR and α3β4 nAChR[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | Ispronicline (10-20 mg/kg; s.c.) induces c-Fos expression in selective regions of the rat forebrain[1]. Ispronicline pharmacokinetics (half-life of 2 h in rats) contrasts with the long-lasting improvement of working memory (18 h to 2 d)[2]. Animal Model: Male Wistar rats weighting 180-200 g[1] Dosage: 10 and 30 mg/kg Administration: s.c. Result: Induced c-Fos in medial paraventricular nucleus of hypothalamus. Treatment with 30 mg/kg ispronicline, but not 10 mg/kg, increased the number of c-Fos immunoreactive cells significantly as compared to controls within the medial parvocellular part of paraventricular nucleus (PVN). |
| References |
| Molecular Formula | C14H22N2O |
|---|---|
| Molecular Weight | 234.34 |
| Exact Mass | 234.17300 |
| PSA | 34.15000 |
| LogP | 3.27090 |
| Storage condition | -20°C |
|
~%
Ispronicline CAS#:252870-53-4 |
| Literature: Targacept, Inc. Patent: US6979695 B2, 2005 ; |
|
~%
Ispronicline CAS#:252870-53-4 |
| Literature: Targacept, Inc. Patent: US6218383 B1, 2001 ; |
|
~%
Ispronicline CAS#:252870-53-4 |
| Literature: TARGACEPT INC.; DULL, Gary Maurice; GENUS, John; RATILAINEN, Tommi; RYBERG, Per Olof; HELLSTROeM, Janna; WAHLSTROeM, Niklas; WAeNNMAN, Thomas Patent: WO2011/146009 A1, 2011 ; Location in patent: Page/Page column 25 ; |
|
~%
Ispronicline CAS#:252870-53-4 |
| Literature: TARGACEPT INC.; DULL, Gary Maurice; GENUS, John; RATILAINEN, Tommi; RYBERG, Per Olof; HELLSTROeM, Janna; WAHLSTROeM, Niklas; WAeNNMAN, Thomas Patent: WO2011/146009 A1, 2011 ; |
|
~%
Ispronicline CAS#:252870-53-4 |
| Literature: TARGACEPT INC.; DULL, Gary Maurice; GENUS, John; RATILAINEN, Tommi; RYBERG, Per Olof; HELLSTROeM, Janna; WAHLSTROeM, Niklas; WAeNNMAN, Thomas Patent: WO2011/146009 A1, 2011 ; |
|
~%
Ispronicline CAS#:252870-53-4 |
| Literature: TARGACEPT INC.; DULL, Gary Maurice; GENUS, John; RATILAINEN, Tommi; RYBERG, Per Olof; HELLSTROeM, Janna; WAHLSTROeM, Niklas; WAeNNMAN, Thomas Patent: WO2011/146009 A1, 2011 ; |
![tert-butyl N-methyl-N-[(2S)-pent-4-en-2-yl]carbamate structure](https://image.chemsrc.com/caspic/092/833453-02-4.png)
| UNII-3E05NBH9V5 |
| (2S)-(4E)-N-methyl-5-[5-isopropoxypyridin-3-yl]-4-penten-2-amine |
| (2S)-(4E)-N-methyl-5-(5-isopropoxy-3-pyridinyl)-4-penten-2-amine |
| (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine |
| (2S)-(4E)-N-methyl-5-(5-isopropoxy-3-pyridyl)-4-penten-2-amine |
| Ispronicline |
| AZD-3480 |
| RJR-1734 |
| Ispronicline (INN/USAN) |